Effect of shengmai san on insulin resistance, tumor necrosis factor-alpha and oxidative stress in rats fed on a high-fat diet

Journal of Food and Drug Analysis

Volumn 19, Issue 1, 2011, Pages 40-48

  Yao, Hsien Tsung ^a   Chiang, Meng Tsan ^b   Lii, Chong Kuei ^a   Chang, Yi Wei ^c   Hsieh, Su Huei ^d   Lin, Jia Hsuan ^a   Chou, Ruey Hwang ^e,f   Yeh, Teng Kuang ^d  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN OCEAN UNIVERSITY   (Taiwan)

^c SunTen Phytotech Co   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

High fat diet; Insulin resistance; Rats; Shengmai san; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CHINESE DRUG; FATTY ACID; FRUCTOSAMINE; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLUTATHIONE PEROXIDASE; HEXOKINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SHENGMAI SAN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFECT; FATTY ACID BLOOD LEVEL; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID DIET; LIPID PEROXIDATION; LIVER; LOW FAT DIET; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS; RATTUS NORVEGICUS;

EID: 79959454705     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Potenza, M. A. and Montagnani, M. 2008. Abnormal insulin signaling: early detection of silent coronary artery disease-erectile dysfunction? Curr. Pharm. Des. 14: 3737-3748.
2. Oudot, A., Behr-Roussel, D., Compagnie, S., Caisey, S., Le Coz, O., Gorny, D., Alexandre, L. and Giuliano, F. 2009. Endothelial dysfunction in insulin resistant rats is associated with oxidative stress and cox pathway dysregulation. Physiol. Res. 58: 499-509.
3. Anuurad, E., Tracy, R. P., Pearson, T. A., Kim, K. and Berglund, L. 2009. Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis 205: 290-295.
4. Balakumar, P. and Singh, M. 2006. Anti-tumour necrosis factor-alpha therapy in heart failure: future directions. Basic Clin. Pharmacol. Toxicol. 99: 391-397.
5. Kaur, K., Sharma, A. K., Dhingra, S. and Singal, P. K. 2006. Interplay of TNF-alpha and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. J. Mol. Cell Cardiol. 41: 1023-1030.
6. Berk, B. C. 2007. Novel approaches to treat oxidative stress and cardiovascular diseases. Trans. Am. Clin. Climatol. Assoc. 118: 209-214.
7. Kalantar-Zadeh, K., Anker, S. D., Horwich, T. B. and Fonarow, G. C. 2008. Nutritional and anti-inflammatory interventions in chronic heart failure. Am. J. Cardiol. 101: 89E-103E.
8. Ko, K. M., Mark, D. H. F., Yin, T. K. and Yan, Y. Q. 2002. Pharmacological studies on Shengmai San. In: K.M. Ko and R. Hardman (Eds.), Shengmai San. Taylor & Francis, pp. 17-40. London and New York.
9. Zhang, Y. C., Chen, R. M., Lu, B. J., Zhao, M. H. and Rong, Y. Z. 2009. Influence of shengmai capsule on recovery of living capacity in patients after myocardial infarction. Chin. J. Integr. Med. 15: 333-336.
10. Zhang, Y. C., Lu, B. J., Zhao, M. H., Rong, Y. Z. and Chen, R. M. 2008. Effect of Shengmai injection on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus. Chin. J. Integr. Med. 14: 281-285.
11. Yang, Y., Yin, C.Y., Yang, Y. and Zhao, S. 2004. Clinical study of effect of shengmai injection on insulin resistance in patients with coronary heart disease. Acta Acad. Med. Wuhan. 13: 363-364.
12. Liu, T. P., Liu, I. M., and Cheng, J. T. 2005. Improvement of insulin resistance by panax ginseng in fructose-rich chow-fed rats. Horm. Metab. Res. 37: 146-151.
13. Rhule, A., Navarro, S., Smith, J. R. and Shepherd, D. M. 2006. Panax notoginseng attenuates LPS-induced pro-inflammatory mediators in RAW264.7 cells. J. Ethnopharmacol. 106: 121-128.
14. You, J. S., Pan, T. L., and Hou, Y. C. 2006. Schisandra chinensis protects against adriamycin-induced cardiotoxicity in rats. Chang Gung Med. J. 29: 63-70.
15. Kou, J., Sun, Y., Lin, Y., Cheng, Z., Zheng, W., Yu, B. and Xu, Q. 2005. Anti-inflammatory activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents. Biol. Pharm. Bull. 28: 1234-1238.
16. Lovejoy, J. C. 1999. Dietary fatty acids and insulin resistance. Curr. Atheroscler. Rep. 1: 215-220.
17. Esposito, E., Iacono, A., Bianco, G., Autore, G., Cuzzocrea, S., Vajro, P., Canani, R. B., Calignano, A., Raso, G. M. and Meli, R. 2009. Probiotics reduce the inflammatory response induced by a high-fat diet in the liver of young rats. J. Nutr. 139: 905-911.
18. Yao, H. T., Chang, Y. W., Chen, C. T., Chiang, M. T., Chang, L. and Yeh, T. K. 2008. Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet. J. Ethnopharmacol. 116: 49-57.
19. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C.1985. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
20. Folch, J., Lees, M. and Sloane-Stanley, G. M. 1957. A purification of total lipid from animal tissue. J. Biol. Chem. 226: 497-509.
21. Carlson, E. and Goldford, S. 1979. A sensitive enzymatic method for determination of free and esterified tissue cholesterol. Clinica. Chimica. Acta. 79: 575-582.
22. Nagayama, F., Ohshima, H. and Umezawa, K. 1972. Distribution of glucose-6-phosphate metabolizing enzymes in fish. Nippon Suisan Gakkaishi 38: 589-593.
23. Mohandas, J., Marshall, J. J., Duggin, G. G., Horvath, J. S. and Tiller, D. J. 1984. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res. 44: 5086-5091. (Pubitemid 15204468)
24. Yao, H. T., Lin, P., Chang, Y. W., Chen, C. T., Chiang, M. T., Chang, L., Kuo, Y. C., Tsai, H. T. and Yeh, T. K. 2009. Effect of taurine supplementation on cytochrome P450 2E1 and oxidative stress in the liver and kidneys of rats with streptozotocin-induced diabetes. Food. Chem. Toxicol. 47: 1703-1709.
25. Yagi, K. 1976. A simple fluorimetric assay for lipid peroxidation in plasma. Biochem. Med. 15: 212-216.
26. Uchiyama, M. and Mihara, M. 1978. Determination of malonaldehyde precursor in tissue by thiobarbituric acid test. Anal. Biochem. 86: 271-278.
27. Newsholme, E. A. and Dimitriadis, G. 2001. Integration of biochemical and physiologic effects of insulin on glucose metabolism. Exp. Clin. Endocrinol. Diabetes. 109: 122-134.
28. Yu, A. S. and Keeffe, E. B. 2002. Nonalcoholic fatty liver disease. Rev. Gastroenterol. Disord. 2: 11-19
29. Seppala-Lindroos, A., Vehkavaara, S., Hakkinen, A. M., Goto, T., Westerbacka, J., Sovijarvi, A., Halavaara, J. and Yki-Jarvinen, H. 2002. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J. Clin. Endocrinol. Metab. 87: 3023-3028.
30. Flanagan, A. M., Brown, J. L., Santiago, C. A., Aad, P. Y., Spicer, L. J. and Spicer, M. T. 2008. High-fat diets promote insulin resistance through cytokine gene expression in growing female rats. J. Nutr. Biochem. 19: 505-513.
31. Yan, E., Durazo, F., Tong, M. and Hong, K. 2007. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr. Rev. 65: 376-384.
32. Yick, P. K., Poon, M. K. T., Ip, S. P. and Ko, K. M. 1998. In vivo antioxidant mechanism of 'Sheng Mai San', A compound formulation. Pharm. Biol. 36: 189-193.
33. You, J. S., Huang, H. F., Chang, Y. L. and Lee, Y. S. 2006. Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats. Am. J. Chin. Med. 34: 295-305.
34. Chater, S., Abdelmelek, H., Douki, T., Garrel, C., Favier, A., Sakly, M. and Ben Rhouma, K. 2006. Exposure to static magnetic field of pregnant rats induces hepatic GSH elevation but not oxidative DNA damage in liver and kidney. Arch. Med. Res. 37: 941-946.
35. Fungwe, T. V., Cagen, L. M., Cook, G. A., Wilcox, H. G. and Heimberg, M. 1993. Dietary cholesterol stimulates hepatic biosynthesis of triglyceride and reduces oxidation of fatty acids in the rat. J Lipid Res. 34: 933-941. (Pubitemid 23182692)
36. Yang, Y., Yin, C. Y., Yang, Y. and Zhao, S. 2004. Clinical study of effect of shengmai injection on insulin resistance in patients with coronary heart disease. Acta Acad. Med. Wuhan. 13: 363-364.
37. Zhang, Y. C., Chen, R. M., Lu, B. J., Zhao, M. H and Rong, Y. Z. 2009. Influence of shengmai capsule on recovery of living capacity in patients after myocardial infarction. Chin. J. Integr. Med. 15: 333-336.
38. Liu, H., Yang, J., Du, F., Gao, X., Ma, X., Huang, Y., Xu, F., Niu, W., Wang, F., Mao, Y., Sun, Y., Lu, T., Liu, C., Zhang, B. and Li, C. 2009. Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metab. Dispos. 37: 2290-2298.
39. Xu, M., Wang, G., Xie, H., Huang, Q., Wang, W. and Jia, Y. 2008. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats. J. Ethnopharmacol. 115: 483-488. (Pubitemid 350299087)
40. Ko, K. M. Ip, S. P., Poon, M. K., Wu, S. S., Che, C. T., Ng, K. H. and Kong, Y. C. 1995. Effect of a lignan-enriched fructus schisandrae extract on hepatic glutathione status in rats: protection against carbon tetrachloride toxicity. Planta Med. 61: 134-137.
41. Guo, L. Y., Hung, T. M., Bae, K. H., Shin, E. M., Zhou, H. Y., Hong, Y. N., Kang, S. S., Kim, H. P. and Kim, Y. S. 2008. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. Eur. J. Pharmacol. 591: 293-299.
42. Li, P. C., Mak, D. H. F., Poon, M. K. T., Ip, S. P. and Ko, K. M. 1996. Myocardial protective effect of Sheng Mai San (SMS) and a lignan-enriched extract of Fructus Schisandrae, in vivo and ex vivo. Phytomedicine 3: 217-321.
43. Cheng, J. T. 2000. Review: Drug therapy in Chinese traditional medicine. J. Clin. Pharmacol. 40: 445-450.